Displaying items by tag: UAB Goal: Research and Scholarship

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

«PrevNext»
Page 87 of 110